Evidence map›Paper›PMID 35062274›Full record

ArticleViruses2021

Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018.

Tali Wagner, Neta S Zuckerman, Tami Halperin, Daniel Chemtob, Itzchak Levy, Daniel Elbirt, Eduardo Shachar, Karen Olshtain-Pops, Hila Elinav, Michal Chowers and 11 more

Abstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Determinants of Direct Costs of HIV-1 Outpatient Care in Israel.International journal of environmental research and public health · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Tali WagnerSackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
Neta S ZuckermanChaim Sheba Medical Center, National HIV-1 and Viral Hepatitis Reference Laboratory, Ramat Gan 5262112, Israel.
Tami HalperinTel-Aviv Sourasky Medical Center, Crusaid Kobler AIDS Center, Tel Aviv 6423906, Israel.
Daniel ChemtobFaculty of Medicine, Braun School of Public Health & Community Medicine, Hebrew University-Hadassah Medical School, Jerusalem 9112102, Israel.
Itzchak LevySackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0003-4716-1293
Daniel ElbirtFaculty of Medicine, Braun School of Public Health & Community Medicine, Hebrew University-Hadassah Medical School, Jerusalem 9112102, Israel.
Eduardo ShacharImmunology Unit, Rambam Health Care Campus, Haifa 3109601, Israel.
Karen Olshtain-PopsHadassah Medical Center, Jerusalem 9112102, Israel.
Hila ElinavFaculty of Medicine, Braun School of Public Health & Community Medicine, Hebrew University-Hadassah Medical School, Jerusalem 9112102, Israel.
Michal ChowersSackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
Valery ItsominHillel Yaffe Medical Center, Hadera 38100, Israel.
Klaris RiesenbergFaculty of Health Sciences, Goldman Medical School, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Marina WaxChaim Sheba Medical Center, National HIV-1 and Viral Hepatitis Reference Laboratory, Ramat Gan 5262112, Israel.
Rachel ShiraziChaim Sheba Medical Center, National HIV-1 and Viral Hepatitis Reference Laboratory, Ramat Gan 5262112, Israel.
Yael GozlanChaim Sheba Medical Center, National HIV-1 and Viral Hepatitis Reference Laboratory, Ramat Gan 5262112, Israel.
Natasha MatusTel-Aviv Sourasky Medical Center, Crusaid Kobler AIDS Center, Tel Aviv 6423906, Israel.
Shirley GirshengornTel-Aviv Sourasky Medical Center, Crusaid Kobler AIDS Center, Tel Aviv 6423906, Israel.
Rotem MaromTel-Aviv Sourasky Medical Center, Crusaid Kobler AIDS Center, Tel Aviv 6423906, Israel.
Ella MendelsonSackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
Dan TurnerSackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
Orna MorSackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0003-3207-4226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the low prevalence of HIV-1 in Israel, continuous waves of immigration may have impacted the local epidemic. We characterized all people diagnosed with HIV-1 in Israel in 2010-2018. The demographics and clinical data of all individuals (

Indexed as

AdultAnti-HIV AgentsAsiaCross-Sectional StudiesDrug Resistance, ViralEuropeEurope, EasternFemaleHIV-1HIV InfectionsHIV SeropositivityHumansIsraelMaleMiddle AgedMutationAnti-HIV AgentsReverse Transcriptase InhibitorsepidemiologyHIV-1 spreadpeople living with HIV-1(PLHIV)transmitted drug-resistance mutations (TDRM)

Identifiers

PMID35062274
PMCPMC8779053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.